Tag: Cardiovascular risk

292. The Vioxx Scandal

by VWheelock | Dec 27, 2017 | Pharmaceutical companies | 0 |

In 1999, the pharmaceutical company Merck introduced the drug Vioxx (Rofecoxib) to be used as an anti-inflammatory treatment for pain associated with osteoarthritis. It was claimed to be effective and safer than other treatments...

New Book by Verner Wheelock

Twitter

Follow @VernersViews

Dr Verner Wheelock
@VernersViews

"There is no reason why a big, well-financed study like this shouldn’t use a double-blind methodology across all tr… https://t.co/UirIHhJBTp
about 15 hours ago
There is no reason why a big, well-financed study like this shouldn’t use a double-blind methodology across all trial arms.
about 15 hours ago
"This is strange, and really quite unforgivable, because it makes it much easier for the researchers to manipulate… https://t.co/YAJSQuek8z
about 15 hours ago
"In other words, in both the British and the Brazilian arm, the researchers knew who was in the vaccine group and w… https://t.co/2FlgncWg8R
about 15 hours ago
"The three arms varied somewhat in terms of the methodology used. The British and Brazilian arms were single-blind,… https://t.co/xEiWYYUIMo
about 15 hours ago

Tag: Cardiovascular risk

292. The Vioxx Scandal

New Book by Verner Wheelock

Categories

Recent Posts

Recent Comments

Twitter